IL TEST CARBAMAZEPHINE— 510(k) K933684

Name: FDA 510(k) clearance K933684
Creator: U.S. Food and Drug Administration
Published: 1993-10-01

Substantially Equivalent

Instrumentation Laboratory CO

FDA 510(k) clearance K933684 for IL TEST CARBAMAZEPHINE, Substantially Equivalent on 1993-10-01. Applicant: Instrumentation Laboratory CO. Device class: 2.

Clearance details

Applicant: Instrumentation Laboratory CO
Product code: Code KLT
Device class: Class 2
Regulation: 21 CFR 862.3645
Advisory panel: Clinical Toxicology
Date received: 1993-07-29
Decision date: 1993-10-01
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Bedford, MA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code KLT

view all

K151578 — Carbamazepine Gen 42015-10-22
K123518 — ABBOTT CARBAMAZEPINE ASSAY2013-06-05
K103627 — ARCHITECT ICARBAMAZEPINE ICARBAMAZEPINE REAGENTS; ARCHITECT ICARBAMAZEPINE CALIBRATORS2011-10-14
K063131 — CARBAMAZEPINE, VALPROIC ACID, TDM CALIBRATION SET B AND ABTROL, NORTROL CONTROLS2007-10-05
K042808 — ADVIA IMS CARBAMAZEPINE METHOD2005-02-08

More clearances from Instrumentation Laboratory CO

view all

K221359 — ACL TOP 970 CL, HemosIL CL Anti-Cardiolipin IgM, HemosIL CL Anti-ß2 Glycoprotein-I IgM2023-09-29
K223187 — HemosIL Liquid Anti-Xa2023-06-23
K223090 — GEM Premier ChemSTAT2023-01-27
K223402 — HemosIL von Willebrand Factor Antigen2022-12-09
K213464 — HemosIL Liquid Anti-Xa2022-10-04

Data sourced from openFDA. This site is unofficial and independent of the FDA.